Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.24 USD | +3.04% | +0.15% | -11.73% |
May. 14 | Oppenheimer Lowers UroGen Pharma Price Target to $32 From $34, Maintains Outperform Rating | MT |
May. 13 | Transcript : UroGen Pharma Ltd., Q1 2024 Earnings Call, May 13, 2024 |
Financials (USD)
Sales 2024 * | 93.99M | Sales 2025 * | 149M | Capitalization | 478M |
---|---|---|---|---|---|
Net income 2024 * | -128M | Net income 2025 * | -108M | EV / Sales 2024 * | 4.15 x |
Net cash position 2024 * | 88.52M | Net cash position 2025 * | 308M | EV / Sales 2025 * | 1.14 x |
P/E ratio 2024 * |
-3.68
x | P/E ratio 2025 * |
-4.51
x | Employees | 204 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 89.16% |
Latest transcript on UroGen Pharma Ltd.
1 day | +3.04% | ||
1 week | +0.15% | ||
Current month | -4.20% | ||
1 month | -6.83% | ||
3 months | -22.53% | ||
6 months | +2.24% | ||
Current year | -11.73% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 62 | 19-01-02 | |
Dong Kim
DFI | Director of Finance/CFO | 47 | 21-07-31 |
Jason Smith
CMP | Compliance Officer | 52 | 20-09-08 |
Members of the board | Title | Age | Since |
---|---|---|---|
Arie Belldegrun
CHM | Chairman | 74 | 12-09-30 |
Cynthia Butitta
BRD | Director/Board Member | 70 | 17-09-30 |
Fred Cohen
BRD | Director/Board Member | 67 | 17-05-15 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +4.20% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 13.24 | +3.04% | 272,413 |
24-05-23 | 12.85 | -3.46% | 255,841 |
24-05-22 | 13.31 | +0.30% | 231,128 |
24-05-21 | 13.27 | +2.79% | 224,667 |
24-05-20 | 12.91 | -2.34% | 208,213 |
Delayed Quote Nasdaq, May 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.73% | 478M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.69% | 21.78B | |
-10.60% | 18.09B | |
-41.25% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- URGN Stock